Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleOrelabrutinib-bruton tyrosine kinase inhibitor-based regimens in the treatment of central nervous system lymphoma: a retrospective study.AuthorsWu, Jing-Jing; Wang, Wen-Hua; Dong, Meng; Ma, Shan-Shan; Zhang, Xu-Dong; Zhu, Li-Nan; Niu, Song-Tao; Ding, Meng-Jie; Zhang, Jie-Ming; Zhang, Lei; Li, Xin; Li, Ling; Sun, Zhen-Chang; Wang, Xin-Hua; Fu, Xiao-Rui; Li, Zhao-Ming; Chang, Yu; Nan, Fei-Fei; Yan, Jia-Qin; Yu, HuiPublicationInvestigational New Drugs, 2022, Vol 40, Issue 3, p650ISSN0167-6997Publication typeArticleDOI10.1007/s10637-022-01219-5